Clin Exp Allergy:英国儿童和成人湿疹流行病学分析

2020-11-27 MedSci原创 MedSci原创

湿疹在整个生命周期中呈双峰分布。研究人员观察到由于种族、地理、性别和社会经济地位的不同,湿疹的发生率和患病率也存在差异,这些差异在整个生命中都有所不同。

尽管湿疹是一种常见的炎症性皮肤病,但当前缺乏对整个生命周期内疾病发病率和患病率的估计。近日,过敏性疾病领域权威杂志Clinical and Experimental Allergy上发表了一篇研究文章,这项研究旨在评估英格兰儿童和成人湿疹发生率和患病率,以及社会人口统计学因素(性别、社会经济地位、种族和地理位置)的变化。

研究人员使用了皇家全科医师研究和监视中心初级保健研究数据库,该数据库纳入了2009年至2018年期间385万名登记的儿童和成人。湿疹的发生率通过首次在初级保健记录中有湿疹的诊断来定义,湿疹患病率通过满足活动性湿疹的诊断标准(在任何一年的时间里,在初级保健记录中出现了两次湿疹记录)来定义。

湿疹发生率在1岁以下的婴儿中最高(每100人每年15.0人),在40-49岁的成年人中最低(每100人每年0.35人),并且从中年到80岁及以上年龄段的人中湿疹发病率有所上升,达到第二小高峰(100人每年0.79人)。2岁儿童的湿疹患病率最高(16.5%),而30-39岁成年人的湿疹患病率最低(2.8%)。男性婴儿(<2岁)和70岁以上的男性湿疹发生率更高;在所有其他年龄段,女性的发病率均较高。与白人相比,湿疹在亚洲和黑人中更为常见。较高的社会经济地位与2岁以下婴儿湿疹发生率较高相关,但在所有其他年龄组中则相反。在城市和英格兰西北部,湿疹的发生率和患病率均较高。

由此可见,湿疹在整个生命周期中呈双峰分布。研究人员观察到由于种族、地理、性别和社会经济地位的不同,湿疹的发生率和患病率也存在差异,这些差异在整个生命中都有所不同。

原始出处:  

Simon de Lusignan.et al.The epidemiology of eczema in children and adults in England: A population‐based study using primary care data.Clin Exp Allergy. 2020.https://onlinelibrary.wiley.com/doi/10.1111/cea.13784

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (4)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1329438, encodeId=cdf0132943811, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Sun Nov 29 12:25:06 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411375, encodeId=575d14113e5ce, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sun Nov 29 12:25:06 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903149, encodeId=abc59031490c, content=继续稳固不同知识内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200627/83a502bff6c14b759a7d0863b4068e7b/32ad40676056418ea58a94afac9c5b81.jpg, createdBy=6f475314305, createdName=水-晶, createdTime=Sat Nov 28 22:28:28 CST 2020, time=2020-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902956, encodeId=4ff09029568a, content=继续来学习新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200627/83a502bff6c14b759a7d0863b4068e7b/32ad40676056418ea58a94afac9c5b81.jpg, createdBy=6f475314305, createdName=水-晶, createdTime=Fri Nov 27 22:36:20 CST 2020, time=2020-11-27, status=1, ipAttribution=)]
    2020-11-29 膀胱癌
  2. [GetPortalCommentsPageByObjectIdResponse(id=1329438, encodeId=cdf0132943811, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Sun Nov 29 12:25:06 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411375, encodeId=575d14113e5ce, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sun Nov 29 12:25:06 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903149, encodeId=abc59031490c, content=继续稳固不同知识内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200627/83a502bff6c14b759a7d0863b4068e7b/32ad40676056418ea58a94afac9c5b81.jpg, createdBy=6f475314305, createdName=水-晶, createdTime=Sat Nov 28 22:28:28 CST 2020, time=2020-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902956, encodeId=4ff09029568a, content=继续来学习新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200627/83a502bff6c14b759a7d0863b4068e7b/32ad40676056418ea58a94afac9c5b81.jpg, createdBy=6f475314305, createdName=水-晶, createdTime=Fri Nov 27 22:36:20 CST 2020, time=2020-11-27, status=1, ipAttribution=)]
    2020-11-29 xugumin
  3. [GetPortalCommentsPageByObjectIdResponse(id=1329438, encodeId=cdf0132943811, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Sun Nov 29 12:25:06 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411375, encodeId=575d14113e5ce, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sun Nov 29 12:25:06 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903149, encodeId=abc59031490c, content=继续稳固不同知识内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200627/83a502bff6c14b759a7d0863b4068e7b/32ad40676056418ea58a94afac9c5b81.jpg, createdBy=6f475314305, createdName=水-晶, createdTime=Sat Nov 28 22:28:28 CST 2020, time=2020-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902956, encodeId=4ff09029568a, content=继续来学习新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200627/83a502bff6c14b759a7d0863b4068e7b/32ad40676056418ea58a94afac9c5b81.jpg, createdBy=6f475314305, createdName=水-晶, createdTime=Fri Nov 27 22:36:20 CST 2020, time=2020-11-27, status=1, ipAttribution=)]
    2020-11-28 水-晶

    继续稳固不同知识内容

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1329438, encodeId=cdf0132943811, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=23, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Sun Nov 29 12:25:06 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1411375, encodeId=575d14113e5ce, content=<a href='/topic/show?id=91e96538eee' target=_blank style='color:#2F92EE;'>#流行病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=19, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=65387, encryptionId=91e96538eee, topicName=流行病)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=30bd35, createdName=xugumin, createdTime=Sun Nov 29 12:25:06 CST 2020, time=2020-11-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=903149, encodeId=abc59031490c, content=继续稳固不同知识内容, beContent=null, objectType=article, channel=null, level=null, likeNumber=75, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200627/83a502bff6c14b759a7d0863b4068e7b/32ad40676056418ea58a94afac9c5b81.jpg, createdBy=6f475314305, createdName=水-晶, createdTime=Sat Nov 28 22:28:28 CST 2020, time=2020-11-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=902956, encodeId=4ff09029568a, content=继续来学习新知识, beContent=null, objectType=article, channel=null, level=null, likeNumber=65, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200627/83a502bff6c14b759a7d0863b4068e7b/32ad40676056418ea58a94afac9c5b81.jpg, createdBy=6f475314305, createdName=水-晶, createdTime=Fri Nov 27 22:36:20 CST 2020, time=2020-11-27, status=1, ipAttribution=)]
    2020-11-27 水-晶

    继续来学习新知识

    0

相关资讯

Int Arch Otorhinolaryngol:耳蜗植入前评估:重度双侧舌前听力损失儿童的临床资料和家族史

巴基斯坦的耳聋患病率高。对深度听力损失患者的临床特征的了解不仅有助于查明原因,也有助于公共卫生干预措施的策略规划。

Int J Pediatr Otorhinolaryngol:先天性巨细胞病毒感染儿童的人工耳蜗植入结果

到目前为止,巨细胞病毒(cCMV)是儿童永久性感音神经性听力损失(SNHL)最常见的非遗传性先天性病因,也是造成发育和神经系统残疾的主要感染性原因。最近,有研究人员阐释了由有症状或无症状的cCMV感染

感染新冠死亡风险5-9岁儿童很低 每增加5岁增0.59%

国际著名学术期刊《自然》最新发表一项新的流行病学模型研究论文称,在新冠病毒(SARS-CoV-2)感染导致死亡风险方面,65岁以下人群按年龄划分在各国一致;5-9岁儿童的感染相关死亡风险最低,年龄每增

JAMA Otolaryngol Head Neck Surg:单侧耳聋儿童的耳蜗植入治疗

最近,有研究人员评估了因单侧耳聋(SSD)而接受人工耳蜗植入的儿童的听觉和患者报告的结果情况,并评估了植入时间、主观结果和人工耳蜗装置使用率之间的关系。

Pediatr Res:糠酸氟替卡松在小儿过敏性鼻炎中的应用:随机对照研究

鼻内皮质类固醇是治疗过敏性鼻炎(AR)最有效的抗炎药。然而在中国国内尚未对儿童鼻内皮质激素的疗效和安全性进行专门研究。最近,有研究人员调查了糠酸氟替卡松鼻腔喷雾剂(FFNS)在中国儿童人群中的疗效和安

Pediatrics:听力损失儿童的早期干预、家长谈话和实用性语言调查

实用语言技能是对话能力的基础,而这一能力的不足与行为问题和识字能力低下有关。耳聋或听力困难儿童在这一能力上表现出显著的延迟。最近,有研究人员确定了与耳聋或听力困难儿童实用语言能力相关的变量。